NORVIR Film-coated tablet Ref.[107212] Active ingredients: Ritonavir

Source: European Medicines Agency (EU)  Revision Year: 2023  Publisher: AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany

Product name and form

Norvir 100 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

White, oval, debossed with “NK” on one side.

Qualitative and quantitative composition

Each film-coated tablet contains 100 mg ritonavir.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Ritonavir

Ritonavir is an orally active peptidomimetic inhibitor of the HIV-1 and HIV-2 aspartyl proteases. Inhibition of HIV protease renders the enzyme incapable of processing the gag-pol polyprotein precursor which leads to the production of HIV particles with immature morphology that are unable to initiate new rounds of infection. Ritonavir has selective affinity for the HIV protease and has little inhibitory activity against human aspartyl proteases. Pharmacokinetic enhancement by ritonavir is based on ritonavir’s activity as a potent inhibitor of CYP3A-mediated metabolism.

List of Excipients

ablet:

Copovidone
Sorbitan laurate
Calcium hydrogen phosphate, anhydrous
Silica, colloidal anhydrous
Sodium stearyl fumarate

Film-coating:

Hypromellose
Titanium dioxide (E171)
Macrogols
Hydroxypropyl cellulose
Talc
Silica, colloidal anhydrous
Polysorbate 80

Pack sizes and marketing

Norvir tablets are supplied in white high density polyethylene (HDPE) bottles closed with polypropylene caps.

Three pack sizes are available for Norvir tablets:

  • 1 bottle of 30 tablets
  • 1 bottle of 60 tablets
  • Multipack containing 90 (3 bottles of 30) film-coated tablets

Not all pack sizes may be marketed.

Marketing authorization holder

AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany

Marketing authorization dates and numbers

EU/1/96/016/005-007

Date of first authorisation: 26 August 1996
Date of latest renewal: 26 August 2006

Drugs

Drug Countries
NORVIR Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.